A lot of blame is being put on the board and the CEO for their actions or lack of them. The truth is that all biotechs have been hammered recently…due to Trump, tarrifs, recession fears, and specific issues such as Opthea when posting. NEU, TLX, PME, Cu6, Imu, etc etc all down, even those that are generating healthy incomes. Could our Board have done better? Maybe (and there’s a board member issue that needs resolving) but not deserving the increasing amount ofcriticism they’ve had.
Heyline you obviously have little time or respect for the capability of the CEO. You’ve blamed him on a number of occasions for the decline in the SP and used a number of derogatory title. Seriously, if I had that lack of faith in the CEO I would have bailed a long time ago!
Look at what you post and what’s its contributing to the general sentiment.
RAC Price at posting:
92.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)